vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Marvell Technology, Inc. (MRVL). Click either name above to swap in a different company.

Marvell Technology, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× Alignment Healthcare, Inc.). Marvell Technology, Inc. runs the higher net margin — 91.7% vs 0.9%, a 90.7% gap on every dollar of revenue. On growth, Marvell Technology, Inc. posted the faster year-over-year revenue change (36.8% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs 20.6%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Marvell Technology, Inc. is an American company, headquartered in Santa Clara, California, which develops and produces semiconductors and related technology. Founded in 1995, the company had more than 6,500 employees as of 2024, with over 10,000 patents worldwide, and an annual revenue of $5.5 billion for fiscal 2024.

ALHC vs MRVL — Head-to-Head

Bigger by revenue
MRVL
MRVL
1.7× larger
MRVL
$2.1B
$1.2B
ALHC
Growing faster (revenue YoY)
MRVL
MRVL
+111.6% gap
MRVL
36.8%
-74.7%
ALHC
Higher net margin
MRVL
MRVL
90.7% more per $
MRVL
91.7%
0.9%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
20.6%
MRVL

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ALHC
ALHC
MRVL
MRVL
Revenue
$1.2B
$2.1B
Net Profit
$11.4M
$1.9B
Gross Margin
51.6%
Operating Margin
17.2%
Net Margin
0.9%
91.7%
Revenue YoY
-74.7%
36.8%
Net Profit YoY
381.1%
EPS (diluted)
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
MRVL
MRVL
Q1 26
$1.2B
Q4 25
$1.0B
$2.1B
Q3 25
$993.7M
$2.0B
Q2 25
$1.0B
$1.9B
Q1 25
$926.9M
$1.8B
Q4 24
$701.2M
$1.5B
Q3 24
$692.4M
$1.3B
Q2 24
$681.3M
$1.2B
Net Profit
ALHC
ALHC
MRVL
MRVL
Q1 26
$11.4M
Q4 25
$-11.0M
$1.9B
Q3 25
$3.7M
$194.8M
Q2 25
$15.7M
$177.9M
Q1 25
$-9.1M
$200.2M
Q4 24
$-31.1M
$-676.3M
Q3 24
$-26.4M
$-193.3M
Q2 24
$-24.0M
$-215.6M
Gross Margin
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
51.6%
Q3 25
50.4%
Q2 25
50.3%
Q1 25
50.5%
Q4 24
23.0%
Q3 24
46.2%
Q2 24
45.5%
Operating Margin
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
-1.0%
17.2%
Q3 25
0.8%
14.5%
Q2 25
2.2%
14.3%
Q1 25
-0.6%
12.9%
Q4 24
-3.2%
-46.4%
Q3 24
-2.8%
-7.9%
Q2 24
-2.7%
-13.1%
Net Margin
ALHC
ALHC
MRVL
MRVL
Q1 26
0.9%
Q4 25
-1.1%
91.7%
Q3 25
0.4%
9.7%
Q2 25
1.5%
9.4%
Q1 25
-1.0%
11.0%
Q4 24
-4.4%
-44.6%
Q3 24
-3.8%
-15.2%
Q2 24
-3.5%
-18.6%
EPS (diluted)
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
$-0.04
$2.20
Q3 25
$0.02
$0.22
Q2 25
$0.07
$0.20
Q1 25
$-0.05
$0.23
Q4 24
$-0.15
$-0.78
Q3 24
$-0.14
$-0.22
Q2 24
$-0.13
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
MRVL
MRVL
Cash + ST InvestmentsLiquidity on hand
$705.6M
$2.7B
Total DebtLower is stronger
$4.5B
Stockholders' EquityBook value
$206.9M
$14.1B
Total Assets
$1.3B
$21.6B
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
MRVL
MRVL
Q1 26
$705.6M
Q4 25
$604.2M
$2.7B
Q3 25
$644.1M
$1.2B
Q2 25
$503.8M
$885.9M
Q1 25
$479.5M
$948.3M
Q4 24
$470.6M
$868.1M
Q3 24
$381.0M
$808.7M
Q2 24
$363.7M
$847.7M
Total Debt
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
$323.2M
$4.5B
Q3 25
$322.7M
$4.5B
Q2 25
$322.3M
$4.2B
Q1 25
$321.9M
$4.1B
Q4 24
$321.4M
$4.1B
Q3 24
$212.0M
$4.1B
Q2 24
$211.7M
$4.1B
Stockholders' Equity
ALHC
ALHC
MRVL
MRVL
Q1 26
$206.9M
Q4 25
$179.3M
$14.1B
Q3 25
$161.9M
$13.4B
Q2 25
$141.0M
$13.3B
Q1 25
$108.1M
$13.4B
Q4 24
$99.9M
$13.4B
Q3 24
$114.5M
$14.2B
Q2 24
$123.7M
$14.5B
Total Assets
ALHC
ALHC
MRVL
MRVL
Q1 26
$1.3B
Q4 25
$1.1B
$21.6B
Q3 25
$1.1B
$20.6B
Q2 25
$1.0B
$20.0B
Q1 25
$895.6M
$20.2B
Q4 24
$782.1M
$19.7B
Q3 24
$692.3M
$20.3B
Q2 24
$716.3M
$20.5B
Debt / Equity
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
1.80×
0.32×
Q3 25
1.99×
0.33×
Q2 25
2.29×
0.32×
Q1 25
2.98×
0.30×
Q4 24
3.22×
0.31×
Q3 24
1.85×
0.29×
Q2 24
1.71×
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
MRVL
MRVL
Operating Cash FlowLast quarter
$128.7M
$582.3M
Free Cash FlowOCF − Capex
$508.8M
FCF MarginFCF / Revenue
24.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
11.27×
0.31×
TTM Free Cash FlowTrailing 4 quarters
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
MRVL
MRVL
Q1 26
$128.7M
Q4 25
$-50.4M
$582.3M
Q3 25
$144.6M
$461.6M
Q2 25
$29.1M
$332.9M
Q1 25
$16.6M
$514.0M
Q4 24
$-8.7M
$536.3M
Q3 24
$26.2M
$306.4M
Q2 24
$23.5M
$324.5M
Free Cash Flow
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
$-55.4M
$508.8M
Q3 25
$139.1M
$414.1M
Q2 25
$21.1M
$214.1M
Q1 25
$8.4M
$444.1M
Q4 24
$-18.0M
$461.3M
Q3 24
$16.9M
$258.2M
Q2 24
$11.8M
$233.0M
FCF Margin
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
-5.5%
24.5%
Q3 25
14.0%
20.6%
Q2 25
2.1%
11.3%
Q1 25
0.9%
24.4%
Q4 24
-2.6%
30.4%
Q3 24
2.4%
20.3%
Q2 24
1.7%
20.1%
Capex Intensity
ALHC
ALHC
MRVL
MRVL
Q1 26
Q4 25
0.5%
3.5%
Q3 25
0.6%
2.4%
Q2 25
0.8%
6.3%
Q1 25
0.9%
3.8%
Q4 24
1.3%
4.9%
Q3 24
1.3%
3.8%
Q2 24
1.7%
7.9%
Cash Conversion
ALHC
ALHC
MRVL
MRVL
Q1 26
11.27×
Q4 25
0.31×
Q3 25
38.77×
2.37×
Q2 25
1.86×
1.87×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons